When you absolutely have to recruit patients on time
Home News
A Phase III oncology clinical study is starting at Accell Clinical Research.
This Phase III study will be performed at 14 sites across Russian Federation and will recruit 65 patients suffering from primary myelofibrosis, post-polycythemia vera myelofibrosis, or post-essential thrombocythemia myelofibrosis over
Accell will participate in the Innovative Drug R&D conference in Russia
Accell Clinical Research will participate in the Adam Smith Conferences' 3rd annual Forum dedicated to Innovative Drug Research and Development in Russia taking place on 21 - 23 November 2012
Patient recruitment expectations exceeded
In an ongoing clinical study in Russian Federation in patients with a recent acute coronary syndrome (ACS) event and type 2 diabetes mellitus (T2D), recruitment expectations were exceeded. Actual enrolment
Accell is expanding its Russian team
Accell’s team in Saint Petersburg, Russia has increased by four new members since January 2012. We welcome our new Clinical Research Associates to the clinical department. Currently openings remain for